mr. dr. J. de Haan

No picture available


  1. The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study

    Soomers, V. L. M. N., Desar, I. M. E., van de Poll-Franse, L. V., van de Sande, M. A. J., de Haan, J. J., Verhoef, C., Vriens, I. J. H., van Houdt, W. J., Bonenkamp, J. J., van der Graaf, W. T. A. & Husson, O., 28-Jul-2020, In : Cancers. 12, 8, p. 1-13 13 p., 2088.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Checkpoint inhibitor-induced colitis shares mucosal histopathological features with inflammatory bowel and graft-versus-host disease

    Lopez, S. H., Kats-Ugurlu, G., Vries, L. D., Groot, M. D., Visschedijk, M., Jalving, M. & Haan, J. D., 1-Jul-2019, In : Cancer Research. 79, 13

    Research output: Contribution to journalMeeting AbstractAcademic

  3. Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for Osteosarcoma

    Oude Munnink, T. H., van der Meer, A., de Haan, J. J., Touw, D. J. & van Kruchten, M., Dec-2019, In : Therapeutic Drug Monitoring. 41, 6, p. 693-695 3 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (13) »

ID: 83648551